Grupo Clínico Asociado en Neurorología

Grupo Clínico Asociado

Cognitive impairment and dementias

Cerebrovascular diseases

Demyelinating diseases

Epilepsy

Extrapyramidal pathology

Pain / headaches

Dr. José Miguel Láinez Andrés
Coordinador
Dr. José Miguel Láinez Andrés
j.miguel.lainez@uv.es, miguel.lainez@sen.es

INVESTIGADORES
R4 Senior

José Miguel Láinez Andrés    

R3 Consolidado
R2 Novel / Emergente

Alejandro Ponz de Tienda
Anna Piera Balbastre
Raquel Chamarro Lázaro
Rosario Gil Gimeno

R1 Predoctoral
STAFF
Colaborador/a

Ana Isabel Pareja Martínez
Antonio Salvador Aliaga
Begoña López Pesquera
Francisco Gascón Giménez
Jésica García Ull
José Andrés Domínguez Morán
José María Salom Juan
José Miguel Santonja Llabata
David García López

Enfermero/a

Miriam Iborra Perales

Técnico/a
Apoyo
Publicaciones
Baseline inflammatory status reveals dichotomic immune mechanisms involved in primary-progressive multiple sclerosis pathology. Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Frontiers in Immunology. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. PMID: 35386690

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment. Santos-Lasaosa S, Belvis R, Cuadrado M, Diaz-Insa S, Gago-Veiga A, Guerrero-Peral A, Huerta M, Irimia P, Lainez J, Latorre G, Leira R, Pascual J, Porta-Etessam J, Sanchez Del Rio M, Viguera J, Pozo-Rosich P. Neurologia. 2022 Jun;37(5):390-402. doi: 10.1016/j.nrleng.2019.03.025. PMID: 35672126

Case Report: exacerbation of relapses following mRNA COVID-19 vaccination in multiple sclerosis: a case series. Quintanilla-Bordas C, Gascon-Gimenez F, Alcala C, Paya M, Mallada J, Silla R, Carratala-Bosca S, Gasque-Rubio R, Castillo J, Casanova B. Frontiers in Neurology. 2022 Apr 27;13:897275. doi: 10.3389/fneur.2022.897275. PMID: 35572939

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis. Vicente C, Lacruz L, Gascon F, Carratala S, Quintanilla-Bordas C, Sanz M, Carcelen-Gadea M, Mallada J, Carreres J, Torres L, Dominguez J, Canizares E, Gil-Perotin S, Cubas L, Rubio R, Castillo-Villalba J, Perez-Miralles F, Casanova B. Frontiers in Neurology. 2022 Oct 28;13:991596. doi: 10.3389/fneur.2022.991596. PMID: 36388220

Remission of graves disease after initiation of ocrelizumab in patients with multiple sclerosis. Casany-Fernandez R, Gascon-Gimenez F, Matarredona Solaz E, Pardo Lozano F, Dominguez-Moran J, Ferri Ciscar J, Real J. Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0398. PMID: 36416241

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress. Lainez J, Ashina M, Belvis R, Diaz-Insa S, Ezpeleta D, Garcia-Azorin D, Gonzalez-Oria C, Guerrero A, Guillem A, Holle-Lee D, Huerta-Villanueva M, Irimia P, Leira R, Pascual J, Porta-Etessam J, Pozo-Rosich P, Rodriguez-Vico J, Sanchez del Rio M, Santos-Lasaosa S, Silberstein S. Revista de Neurologia. 2021 Jun 30;72(s02):S1-S19. doi: 10.33588/rn.72s02.2021155. PMID: 34180043

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis. Perez-Miralles F, Prefasi D, Garcia-Merino A, Ara J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno-Garcia S, Maurino J, Carreres-Polo J, Casanova B. Brain and Behavior. 2021 Apr;11(4):e02044. doi: 10.1002/brb3.2044. PMID: 33486890

Document of revision and updating of medication overuse headache (MOH). Gonzalez-Oria C, Belvis R, Cuadrado M, Diaz-Insa S, Guerrero-Peral A, Huerta M, Irimia P, Lainez Andrés J, Latorre G, Leira R, Oterino A, Pascual J, Porta-Etessam J, Pozo-Rosich P, Sanchez Del Rio M, Santos-Lasaosa S. Neurologia. 2021 Apr;36(3):229-240. doi: 10.1016/j.nrl.2020.04.029. PMID: 32917437

Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery. Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich P, Lainez Andrés J. Neurologia. 2021;36(1):61-79. doi: 10.1016/j.nrl.2020.04.022. PMID: 32718873

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project. Santos Garcia D, Blazquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, Garcia Ruiz P, Grandas F, Kulisevsky J, Lopez-Manzanares L, Martinez Castrillo J, Mir P, Pagonabarraga J, Perez-Errazquin F, Salom J, Tijero B, Valldeoriola F, Yanez R, Aviles A, Luquin M. Brain Sciences. 2021 Jul 31;11(8):1027. doi: 10.3390/brainsci11081027. PMID: 34439646

Rituximab for the treatment of generalised myasthenia gravis: experience in clinical practice. Martinez-Monte E, Gascon-Gimenez F, Dominguez-Moran JA, Lainez-Andres JM. Revista de Neurologia. 2021 Nov 16;73(12):416-420. doi: 10.33588/rn.7312.2021166. PMID: 34877644

Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study). Perez-Miralles F, Prefasi D, Garcia-Merino A, Ara J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno-Garcia S, Medrano N, Maurino J, Casanova B. Multiple Sclerosis And Related Disorders. 2021 Feb 23;50:102860. doi: 10.1016/j.msard.2021.102860. PMID: 33647591

The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish. Gallardo V, Alpuente A, Cerda-Company X, Torres-Ferrus M, Del Rio M, Lainez J, Leira R, Trochet J, Pozo-Rosich P. Headache. 2021 Oct;61(9):1403-1410. doi: 10.1111/head.14225. PMID: 34601726

Tinnitus and tinnitus disorder: Theoretical and operational definitions (an international multidisciplinary proposal). De Ridder D, Schlee W, Vanneste S, Londero A, Weisz N, Kleinjung T, Shekhawat G, Elgoyhen A, Song J, Andersson G, Adhia D, de Azevedo A, Baguley D, Biesinger E, Binetti A, Del Bo L, Cederroth C, Cima R, Eggermont J, Figueiredo R, Fuller T, Gallus S, Gilles A, Hall D, Van de Heyning P, Hoare D, Khedr E, Kikidis D, Kleinstaeuber M, Kreuzer P, Lai J, Lainez J, Landgrebe M, Li L, Lim H, Liu T, Lopez-Escamez J, Mazurek B, Moller A, Neff P, Pantev C, Park S, Piccirillo J, Poeppl T, Rauschecker J, Salvi R, Sanchez T, Schecklmann M, Schiller A, Searchfield G, Tyler R, Vielsmeier V, Vlaeyen J, Zhang J, Zheng Y, de Nora M, Langguth B. Progress in Brain Research. 2021;260:1-25. doi: 10.1016/bs.pbr.2020.12.002. PMID: 33637213

CSF chitinase 3-like-1 association with disability of primary progressive MS. Perez Miralles F, Prefasi D, Garcia Merino A, Gascon Gimenez F, Medrano N, Castillo Villalba J, Cubas L, Alcala C, Gil Perotin S, Gomez Ballesteros R, Maurino J, Alvarez Garcia E, Casanova B. Neurology Neuroimmunology & Neuroinflammation. 2020 Jul 1;7(5):e815. doi: 10.1212/NXI.0000000000000815. PMID: 32611760

Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs. Santamarina E, Bertol V, Garayoa V, Garcia-Gomara M, Garamendi-Ruiz I, Giner P, Aranzabal I, Piera Balbastre A, Arcos C, Esteve P, Marinas A, Garcia-Escriva A, Viloria-Alebesque A, Loro F, Ponz De Tienda A, Olivan J, Bonet M, Davila-Gonzalez P, Sivera R, Molins A, Sansa G, Roche J, Martinez A, Monteagudo S, Casadevall T. Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. PMID: 33096456

Evaluation of the concomitant use of oral preventive treatments and Onabotulinumtoxin A in chronic migraine: the PREVENBOX study. Alpuente A, Gallardo V, Torres-Ferrus M, Santos-Lasaosa S, Guerrero A, Lainez Andrés J, Viguera J, Gago-Veiga A, Irimia P, Del Rio M, Pozo-Rosich P. European Journal of Neurology. 2020 Oct;27(10):2102-2108. doi: 10.1111/ene.14331. PMID: 32421912

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine. Santos-Lasaosa S, Cuadrado M, Gago-Veiga A, Guerrero-Peral A, Irimia P, Lainez Andrés J, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera Romero J, Pozo-Rosich P. Neurologia. 2020 Oct;35(8):568-578. doi: 10.1016/j.nrl.2017.09.003. PMID: 29169811

Will neurological care change over the next 5 years due to the COVID-19 pandemic?. Matias-Guiu J, Matias-Guiu J, Alvarez-Sabin J, Ramon Ara J, Arenillas J, Casado-Naranjo I, Castellanos M, Jimenez-Hernandez M, Lainez Andrés J, Moral E, Morales A, Rodriguez-Antiguedad A, Segura T, Serrano-Castro P, Diez-Tejedor E. Neurologia. 2020 May;35(4):252-257. doi: 10.1016/j.nrl.2020.04.006. PMID: 32364126

+ Información
Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery. Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich P, Lainez Andrés J. Neurologia. 2021;36(1):61-79. doi: 10.1016/j.nrl.2020.04.022. PMID: 32718873

Título: Vagus nerve stimulator en epilepsia fármaco-resistente
Doctorando: Suller Marti, Ana
Director: Láinez Andres, Jose Miguel
Fecha: 21/03/2022
Universidad: Universitat de València

Título: Tratamiento endovascular en el ictus isquémico agudo. Análisis de factores pronóstico y de identificación etiológica
Doctorando: Piera Balbastre, Ana
Director: Láinez Andres, Jose Miguel; Ponz De Tienda, Alejandro
Fecha: 15/12/2020
Universidad: Universitat de València